The Firm
What We Do
News & Insights
PARTNER LOGIN
Media Relations
press@buxtonhelmsley.com
+1 (212) 561-5540, Option 4
Status
Active
View All Campaigns
Share
Back to Campaigns
Assertio Holdings, Inc.
Active
Media Relations
press@buxtonhelmsley.com
+1 (212) 561-5540, Option 4
View All Campaigns
March 22, 2025
•
1 min read
Overview
Assertio Holdings Inc (NASDAQ: ASRT)
Campaign Materials
BH
Buxton Helmsley
Media Coverage,
News
MedPageToday – Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
#Assertio Holdings, Inc. (ASRT)
November 22, 2024
BH
MedPageToday – Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
#Assertio Holdings, Inc. (ASRT)
Nov 22, 2024
Media Coverage +1
BH
Buxton Helmsley
Campaign Materials,
Resources
Open Letter to U.S. Senate
#Assertio Holdings, Inc. (ASRT)
November 15, 2024
BH
Open Letter to U.S. Senate
#Assertio Holdings, Inc. (ASRT)
Nov 15, 2024
Campaign Materials +1
BH
Buxton Helmsley
News,
Press Releases
Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio
#Assertio Holdings, Inc. (ASRT)
November 15, 2024
•
7 min read
BH
Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio
#Assertio Holdings, Inc. (ASRT)
Nov 15, 2024
•
7 min read
News +1
BH
Buxton Helmsley
Campaign Materials,
Resources
EVIDENCE – E-Mail from Spectrum Employee Asked to Delete Adverse Events from Clinical Data
#Assertio Holdings, Inc. (ASRT)
November 11, 2024
BH
EVIDENCE – E-Mail from Spectrum Employee Asked to Delete Adverse Events from Clinical Data
#Assertio Holdings, Inc. (ASRT)
Nov 11, 2024
Campaign Materials +1
ALL CAMPAIGN MATERIALS